KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,554 | -1.2% | 185,809 | 0.0% | 0.29% | +4.3% |
| Q2 2023 | $21,814 | +20.7% | 185,809 | -17.7% | 0.28% | +13.7% |
| Q1 2023 | $18,078 | +1.1% | 225,809 | 0.0% | 0.25% | +4.6% |
| Q4 2022 | $17,889 | -99.9% | 225,809 | 0.0% | 0.24% | +9.2% |
| Q3 2022 | $15,739,000 | +6.2% | 225,809 | 0.0% | 0.22% | +16.7% |
| Q2 2022 | $14,827,000 | -1.3% | 225,809 | 0.0% | 0.19% | +13.4% |
| Q1 2022 | $15,025,000 | +15.6% | 225,809 | +21.5% | 0.16% | +33.3% |
| Q4 2021 | $12,997,000 | +34.0% | 185,809 | 0.0% | 0.12% | +23.0% |
| Q3 2021 | $9,701,000 | -23.2% | 185,809 | 0.0% | 0.10% | -23.1% |
| Q2 2021 | $12,635,000 | -11.7% | 185,809 | 0.0% | 0.13% | -7.1% |
| Q1 2021 | $14,315,000 | +28.4% | 185,809 | 0.0% | 0.14% | +25.0% |
| Q4 2020 | $11,149,000 | +39.4% | 185,809 | 0.0% | 0.11% | +24.4% |
| Q3 2020 | $7,999,000 | +42.2% | 185,809 | +36.8% | 0.09% | +36.4% |
| Q2 2020 | $5,625,000 | -4.2% | 135,809 | 0.0% | 0.07% | -19.5% |
| Q1 2020 | $5,872,000 | – | 135,809 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
| S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
| First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
| Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
| Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
| Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
| HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
| DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
| Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
| Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |